Xiaoying Xue

机构：Hebei Medical University, Second Hospital of Hebei Medical University · ORCID：0000-0002-4934-2904

发表论文 94 篇 · 总被引 784 次 · h-index 15

代表论文

• IDH1R132H mutation increases radiotherapy efficacy and a 4-gene radiotherapy-related signature of WHO grade 4 gliomas (2023 · Scientific Reports · 被引 13)
• HMGB2 is a biomarker associated with poor prognosis promoting radioresistance in glioma by targeting base excision repair pathway (2024 · Translational Oncology · 被引 10)
• Pediatric H3K27M‑mutant diffuse midline glioma with vertebral metastasis: A case report and literature review (2023 · Oncology Letters · 被引 5)
• Prognostic factors in pediatrics TAPVC: a 10-year retrospective study (2025 · Scientific Reports · 被引 4)
• Impact of heart motion on radiation dose in the heart and left ventricular myocardium during breast cancer treatment (2025 · Frontiers in Oncology · 被引 2)
• The Prognostic Significance of TMSB4X in Glioma Patients (2025 · International Journal of General Medicine · 被引 2)